全文获取类型
收费全文 | 164614篇 |
免费 | 32022篇 |
国内免费 | 2487篇 |
专业分类
耳鼻咽喉 | 5264篇 |
儿科学 | 5562篇 |
妇产科学 | 2585篇 |
基础医学 | 4943篇 |
口腔科学 | 1831篇 |
临床医学 | 27912篇 |
内科学 | 50909篇 |
皮肤病学 | 7587篇 |
神经病学 | 16072篇 |
特种医学 | 6792篇 |
外科学 | 43269篇 |
综合类 | 317篇 |
现状与发展 | 72篇 |
一般理论 | 4篇 |
预防医学 | 7905篇 |
眼科学 | 3482篇 |
药学 | 1846篇 |
中国医学 | 25篇 |
肿瘤学 | 12746篇 |
出版年
2024年 | 699篇 |
2023年 | 4879篇 |
2022年 | 1397篇 |
2021年 | 3541篇 |
2020年 | 6244篇 |
2019年 | 2599篇 |
2018年 | 7928篇 |
2017年 | 7679篇 |
2016年 | 8751篇 |
2015年 | 8835篇 |
2014年 | 16060篇 |
2013年 | 16321篇 |
2012年 | 6672篇 |
2011年 | 6712篇 |
2010年 | 10995篇 |
2009年 | 14779篇 |
2008年 | 6708篇 |
2007年 | 4945篇 |
2006年 | 7258篇 |
2005年 | 4595篇 |
2004年 | 3752篇 |
2003年 | 2666篇 |
2002年 | 2743篇 |
2001年 | 3896篇 |
2000年 | 3068篇 |
1999年 | 3304篇 |
1998年 | 3773篇 |
1997年 | 3534篇 |
1996年 | 3430篇 |
1995年 | 3272篇 |
1994年 | 1990篇 |
1993年 | 1615篇 |
1992年 | 1412篇 |
1991年 | 1458篇 |
1990年 | 1079篇 |
1989年 | 1203篇 |
1988年 | 1032篇 |
1987年 | 866篇 |
1986年 | 917篇 |
1985年 | 754篇 |
1984年 | 569篇 |
1983年 | 543篇 |
1982年 | 532篇 |
1981年 | 415篇 |
1980年 | 376篇 |
1979年 | 323篇 |
1978年 | 338篇 |
1977年 | 400篇 |
1975年 | 286篇 |
1972年 | 309篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves
a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because
of the heterogeneity of the illness, management should be individualized for the patient. Pharmacologic treatment should address
issues of pain control, sleep disturbance, fatigue, and any underlying coexisting mood disorder. Nonpharmacologic treatment
should include patient education, a regular exercise and stretching program, and cognitive behavioral therapy. All of these
are essential to improving functional capacity and quality of life. This review provides general guidelines in initiating
a successful pharmacologic treatment program for patients with fibromyalgia. 相似文献
13.
14.
15.
Pascal Thomas Gilbert Massard Henri Porte Christophe Doddoli Xavier Ducrocq Massimo Conti 《European journal of cardio-thoracic surgery》2006,29(6):880-885
Objective: To investigate on the feasibility, safety, and effectiveness of a new bioabsorbable material for lung staple-line reinforcement. Methods: This prospective open trial included 66 patients (mean age of 56 ± 17 years) who underwent various types of lung resection using staplers with knitted calcium alginate sleeves for buttressing (FOREseal™, Laboratoires Brothier, Nanterre, France) at three academic centers: 29 lobectomies, 22 emphysema surgeries, 15 wedge resections or lung biopsies. Intraoperative air leakage was assessed at a mean respiratory peak pressure of 30 cmH2O, and rated as grade 1, 2, or 3. Persistent air leakage in the postoperative course, as well as any relevant event, was assessed daily. The follow-up period was of 6 months. Results: No technical problem linked to the device occurred. Hemostasis of the cutting edges was completed in all patients. Fifty-six percent of the patients had no intraoperative air leak and 27.3% had grade 1 leaks. Mean postoperative air leaks and thoracic drainage times were 1.9 ± 2.3 days and 6 ± 5.3 days, respectively. In-hospital mortality was nil. There was no empyema. Mean hospital stay was 9.1 ± 6.6 days. At follow-up, one patient underwent lung transplantation, and pathology of the explanted specimen showed the absence of device-related foreign-body inflammation. One patient complained from metalloptysis, and another one, with a metastatic invasive aspergillosis, developed an infectious recurrence that required reoperation. Conclusions: FOREseal is an ergonomic, safe, and promising new material instead of nonabsorbable materials and xenomaterials for staple-line reinforcement. A randomized comparative study is now in progress. 相似文献
16.
Sergue? O Fetissov Jarmila Hallman Ida Nilsson Ann-Kari Lefvert Lars Oreland Tomas H?kfelt 《Neuropsychopharmacology》2006,60(8):799-802
BACKGROUND: Altered stress response is characteristic for subjects with abnormal aggressive and antisocial behavior, but the underlying biological mechanisms are unclear. We hypothesized that autoantibodies (autoAbs) directed against several stress-related neurohormones may exist in aggressive subjects. METHODS: Using enzyme-linked immunosorbent assay, we studied whether autoAbs directed against corticotropin (ACTH), alpha-melanocyte-stimulating hormone (alpha-MSH), oxytocin, and vasopressin are present in serum of male subjects with conduct disorder and prisoners with history of violence. Healthy blood donors served as control subjects. RESULTS: Both conduct disorder and prisoners groups displayed strongly increased levels of ACTH-reactive immunoglobulin G (IgG) and immunoglobulin M (IgM) autoAbs compared with control subjects. Levels of oxytocin-reactive IgM autoAbs were slightly increased in both groups of aggressive subjects, whereas levels of vasopressin-reactive IgG and IgM autoAbs were lower only in conduct disorder. No differences in the levels of alpha-MSH-reactive autoAbs were found between aggressive and control subjects. CONCLUSIONS: High levels of ACTH-reactive autoAbs as well as altered levels of oxytocin- and vasopressin-reactive autoAbs found in aggressive subjects may interfere with the neuroendocrine mechanisms of stress and motivated behavior. Our data suggest a new biological mechanism of human aggressive behavior that involves autoAbs directed against several stress-related neurohormones. 相似文献
17.
18.
19.
20.
Lucia Nogovà MD Volker Diehl MD Andreas Engert MD 《Current hematologic malignancy reports》2006,1(1):60-65
Lymphocyte-predominant Hodgkin’s lymphoma (LPHL) differs in histologic and clinical presentation from classical Hodgkin’s
lymphoma (cHL). Treatment of LPHL patients using standard Hodgkin’s lymphoma protocols leads to complete remission in more
than 95% of patients. Survival and freedom from treatment failure are substantially worse in advanced-stage patients than
for early-stage patients. Thus, patients in advanced stages and those in early stages with unfavorable risk factors should
be treated similar to those with cHL. In contrast, patients with early-stage LPHL without risk factors might be sufficiently
treated with reduced-intensity programs having less severe adverse effects. As a result, treatment of early LPHL is rather
heterogeneous, including radiotherapy using extended-fleld technique, involved-fleld radiotherapy (IF-RT), combined-modality
treatment, and, more recently, monoclonal antibodies. Watch-and-wait strategy plays an important role in pediatric oncology,
to avoid adverse effects associated with therapy. IF-RT seems to be emerging as a treatment of choice for patients with stage
IA LPHL; most larger study groups, such as the German Hodgkin Study Group and the European Organisation for Research and Treatment
of Cancer, have adopted IF-RT as the treatment of choice for these patients. 相似文献